Document is current
Any future updates will be listed below
-
Authors
Riddy, Darren M https://orcid.org/0000-0003-0524-1498
Kammoun, Helene L
Murphy, Andrew J
Bosnyak-Gladovic, Sanja
De la Fuente Gonzalez, Rocio
Merlin, Jon https://orcid.org/0000-0002-0062-795X
Ziemann, Mark
Fabb, Stewart
Pierce, Tracie L
Diepenhorst, Natalie
Rueda, Patricia
El-Osta, Assam
Gautier, Jean-Francois
Venteclef, Nicolas
Charman, William N
Christopoulos, Arthur
Sexton, Patrick M
Summers, Roger J
Febbraio, Mark A
Delerive, Philippe
Langmead, Christopher J
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02368704 at ClinicalTrials.govnct02671864 at ClinicalTrials.govDocuments that mention this clinical trial
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
https://doi.org/10.1136/bmjdrc-2021-002285
nct02671864 at ClinicalTrials.govDocuments that mention this clinical trial
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
https://doi.org/10.1136/bmjdrc-2021-002285
Documents that mention this clinical trial
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
https://doi.org/10.1136/bmjdrc-2021-002285
-
Funding
Funding for this research was provided by:
Servier (N/A)
- License Information
